Apexicon
Loading...Apexicon Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
History
There is currently no drug history available for this drug.
Other Information
ApexiCon® Ointment (diflorasone diacetate ointment USP 0.05%) contains 0.5 mg diflorasone diacetate in an ointment base.
Chemically, diflorasone diacetate is 6α,9-difluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione 17,21- diacetate with the molecular formula C26H32F2O7 and a molecular weight of 494.54. The structural formula is represented below:
Each gram of ApexiCon® Ointment (diflorasone diacetate ointment USP 0.05%), for topical administration, contains 0.5 mg diflorasone diacetate in an ointment base consisting of propylene glycol, glyceryl monostearate and white petrolatum.
Sources
Apexicon Manufacturers
-
Pharmaderm, A Division Of Nycomed Us Inc.
![Apexicon (Diflorasone Diacetate Ointment) Ointment [ Pharmaderm, A Division Of Nycomed Us Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Apexicon | Pharmaderm, A Division Of Nycomed Us Inc.
ApexiCon® Ointment (diflorasone diacetate ointment USP 0.05%) should be applied to the affected area as a thin film from one to three times daily depending on the severity or resistant nature of the condition.
Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions.
If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
Login To Your Free Account